## Mechanism of HPV-Mediated Cervical Neoplasia ### Viral Integration and Oncogenic Transformation **Key Point:** High-risk HPV types (16, 18, 31, 33) cause cervical cancer through viral integration into the host genome, which disrupts the viral E2 gene and leads to constitutive overexpression of E6 and E7 oncoproteins. ### The E6 and E7 Oncoproteins 1. **E6 oncoprotein** binds to and degrades p53 (the "guardian of the genome"), preventing apoptosis and cell cycle arrest 2. **E7 oncoprotein** binds to and inactivates Rb (retinoblastoma protein), leading to uncontrolled G1/S transition and loss of cell cycle control ### Progression Model ```mermaid flowchart TD A[HPV-16 infection of basal epithelial cells]:::outcome --> B[Viral episomal replication]:::outcome B --> C{Persistent infection?}:::decision C -->|Clearance| D[Resolution]:::outcome C -->|Persistence| E[Viral integration into host genome]:::action E --> F[Disruption of E2 gene]:::outcome F --> G[Overexpression of E6 and E7]:::action G --> H[p53 degradation + Rb inactivation]:::action H --> I[Loss of apoptosis and cell cycle control]:::urgent I --> J[CIN 1 → CIN 2 → CIN 3 → Invasive cancer]:::urgent ``` **High-Yield:** The transition from episomal to integrated viral DNA is the critical step in malignant transformation. Integration typically occurs at CIN 2–3 stage and is found in >90% of cervical cancers. **Clinical Pearl:** This patient's CIN 2 with HPV-16 positivity has a ~40% risk of progression to CIN 3 or cancer if untreated, justifying excisional treatment (LEEP/cold knife conization). ### Why Integration Matters - **Episomal HPV** (early infection): viral replication is controlled by E2 repressor; usually cleared by immune system within 1–2 years - **Integrated HPV** (persistent infection): E2 gene is disrupted, E6/E7 are constitutively expressed, leading to immortalization and malignant transformation [cite:Robbins 10e Ch 7]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.